Al Shamsi Mariam,Shahin Allen,Iwakura Yoichiro,Lukic Miodrag L,Mensah-Brown Eric PK (2013) Pam3CSK(4) enhanced beta cell loss and diabetogenesis: The roles of IFN-gamma and IL-17, CLINICAL IMMUNOLOGY, vol. 149, br. 1, str. 86-96 (Article) 

Lukic Miodrag L,Volarevic Vladislav B,Mensah-Brown Eric PK,Shahin Allen (2010) ST2 deficiency enhances the severity of Th1/Th-17 mediated inflammation, JOURNAL OF IMMUNOLOGY, vol. 184, br. , str. - (Meeting Abstract) 

Zdravkovic Nemanja S,Shahin Allen,Arsenijevic Nebojsa N,Lukic Miodrag L,Mensah-Brown EPK (2009) Regulatory T cells and ST2 signaling control diabetes induction with multiple low doses of streptozotocin, MOLECULAR IMMUNOLOGY, vol. 47, br. 1, str. 28-36 (Article) 

Jiang Hui-Rong,Al Rasebi Zakeya,Mensah-Brown EPK,Shahin Allen,Xu Damo M,Goodyear Carl S,Fukada Sandra Y,Liu F-T,Liew Foo Y,Lukic Miodrag L (2009) Galectin-3 Deficiency Reduces the Severity of Experimental Autoimmune Encephalomyelitis, JOURNAL OF IMMUNOLOGY, vol. 182, br. 2, str. 1167-1173 (Article) 

Mensah-Brown Eric PK,Rabesi ZA,Shahin Allen,Al Shamsi Mariam,Arsenijevic Nebojsa N,Hsu Daniel K,Liu F-T,Lukic Miodrag L (2009) Targeted disruption of the galectin-3 gene results in decreased susceptibility to multiple low dose streptozotocin-induced diabetes in mice, CLINICAL IMMUNOLOGY, vol. 130, br. 1, str. 83-88 (Article) 

Jiang Hui-Rong,Rasebi ZA,Mensah-Brown EPK,Shahin Allen,Xu Damo M,Goodyear Carl S,Fukada Sandra Y,Liu F-T,Liew Foo Y,Lukic Miodrag L (2008) Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis, IMMUNOLOGY, vol. 125, br. , str. 139-139 (Meeting Abstract) 

Mensah-Brown Eric PK,Shahin Allen,Al-Shamisi M,Wei XG,Lukic Miodrag L (2006) IL-23 leads to diabetes induction after subdiabetogenic treatment with multiple low doses of streptozotocin, EUROPEAN JOURNAL OF IMMUNOLOGY, vol. 36, br. 1, str. 216-223 (Article) 

Mensah-Brown EPK,Stosic-Grujicic Stanislava D,Maksimovic Danijela D,Jasima A,Shahin Allen,Lukic Miodrag L (2002) Downregulation of apoptosis in the target tissue prevents low-dose streptozotocin-induced autoimmune diabetes, MOLECULAR IMMUNOLOGY, vol. 38, br. 12-13, str. 941-946 (Article)